Endocrinology Vol. 138, No. 5 2033-2042
Copyright © 1997 by The Endocrine Society
Insulin and Insulin-Like Growth Factor-I Inhibit the L-Type Calcium Channel Current in Rat Pinealocytes1
Constance L. Chik2,
Bing Li2,
Edward Karpinski and
Anthony K. Ho
Department of Medicine (C.L.C.) and Department of Physiology (B.L.,
E.K., A.K.H.), University of Alberta, Edmonton, Alberta, Canada
Address all correspondence and requests for reprints to: C.L. Chik, Room 733 MSB, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
 |
Abstract
|
|---|
Tyrosine phosphorylation has recently been shown to modulate ion
channel activity. In the present study, the effect of growth factors on
the L-type Ca2+ channel current in rat pinealocytes was
investigated using the whole cell version of the patch clamp technique.
Both insulin and insulin-like growth factor-I (IGF-I) inhibited the
L-type Ca2+ channel current. This inhibition was dependent
on concentration, with median effective concentration
(EC50) values of 60 nM for insulin and 0.14
nM for IGF-I. Heat-inactivated insulin or IGF-I had no
effect on the L-type Ca2+ channel current. The presence of
anti-IGF-I receptor antibodies blocked the inhibitory effect of IGF-I
on the L-type Ca2+ channel current. Two other growth
factors, nerve growth factor and epidermal growth factor, had no effect
on this current. The effects of insulin and IGF-I were blocked by
lavendustin A, a tyrosine kinase inhibitor. Calphostin C, a protein
kinase C inhibitor, attenuated the effect of insulin and IGF-I, whereas
wortmannin, a phosphatidylinositol 3-kinase inhibitor, was ineffective.
These observations indicate that insulin and IGF-I inhibit the L-type
Ca2+ channel current in rat pinealocytes, and that tyrosine
phosphorylation is involved in these effects of insulin and IGF-I.
 |
Introduction
|
|---|
GROWTH FACTORS such as insulin,
insulin-like growth factors (IGFs), epidermal growth factor (EGF), and
nerve growth factor (NGF), as well as their specific receptors, have
been identified in the central nervous system (1, 2, 3). The effects of
growth factors on developing neurons are well established (4). In
addition to long-term effects such as growth and differentiation,
several acute effects of growth factors have been demonstrated in
dividing cells. These include pH changes, membrane hyperpolarization,
increased intracellular Ca2+ levels, and the activation of
enzymes, including phospholipase C-
and phosphatidylinositol
3-kinase (PI3-K) (5, 6). A recently recognized acute effect of growth
factors is their ability to regulate various ion channel activity
including the L-type Ca2+ channel (L-channel) (7, 8, 9, 10, 11).
Tyrosine phosphorylation is involved in this regulation (12), because
the effects of growth factors are blocked by tyrosine kinase inhibitors
(7, 10, 11).
Using tyrosine kinase inhibitors, we recently showed that tyrosine
phosphorylation plays an important role in the regulation of pineal
function (13, 14). The specific growth factors involved in these
effects in the pineal, however, remain unknown. The IGFs are of
particular interest because of the presence of IGF receptors and the
high levels of IGF messenger RNA present in the pineal gland during
development (15, 16, 17). The observation that IGF-I has a modulating
effect on L-channels in two different cell lines of neural and
neuroendocrine origin (7, 10) suggests that these channels may be
modulated by IGF-I in the rat pinealocyte. The L-channels in rat
pinealocytes have been characterized (18, 19) and in the chick pineal
gland, these channels are important in the induction of
N-acetyltransferase and melatonin synthesis (20, 21).
The purpose of this study was to determine 1) the effects of insulin
and IGF-I on the L-channel current; 2) whether other growth factors
such as EGF and NGF have an effect on the L-channel current; and 3) the
mechanisms through which growth factors regulate these channels. We
found that the L-channel current in rat pinealocytes was inhibited by
insulin and IGF-I, and that EGF and NGF had no effect. Furthermore, the
effects of insulin and IGF-I were blocked by a specific tyrosine kinase
inhibitor.
 |
Materials and Methods
|
|---|
Materials
Insulin, 4ß phorbol 12-myristate 13-acetate (PMA), and
nifedipine were obtained from Sigma Chemical Corp. (St. Louis, MO). Bay
K 8644, calphostin C, lavendustin A, lavendustin B, wortmannin, and
anti-IGF-I receptor antibodies were obtained from Calbiochem Corp (San
Diego, CA). IGF-I was a gift from Dr. R. Couch (Department of
Pediatrics, University of Alberta), and NGF was a gift from Dr. K.
Siminoski (Edmonton Endocrine Centre). Cs2-aspartate was
prepared by Dr. H.J. Liu (Department of Chemistry, University of
Alberta). All other chemicals were of the purest grades available and
were obtained commercially. [125I]cAMP and
[125I]cGMP were obtained from ICN ImmunoBiologicals
(Lisle, IL), and antibodies for the RIA of cAMP and cGMP were gifts
from Dr. A. Baukal (National Institute of Child Health and Human
Development, NIH, Bethesda, MD).
Cell preparations
Male Sprague-Dawley rats (150 g) were decapitated after cervical
dislocation. Pinealocytes were then prepared by trypsinization as
described previously (22). The cells were suspended in DMEM containing
10% FCS and maintained overnight at 37 C in a mixture of 95% air and
5% CO2.
Ca2+ channel current recordings were obtained using
the whole cell version of the patch clamp technique (23). Patch
electrodes were pulled from borosilicate glass capillary tubes (outer
diameter = 1.2 mm, inner diameter = 0.9 mm, FHC, Brunswick, ME)
and heat polished. They were filled with a solution containing (in
mM): 70 Cs2-aspartate, 20 HEPES, 11 EGTA, 1
CaCl2, 5 MgCl2.6H2O, 5 glucose, 5
ATP-Na2, and 5 K-succinate. Creatine phosphokinase (50
U/ml) and phospho-creatine-Na2 (20 mM) were
added to the pipette solution to reduce current run down. The bath
solution contained (in mM): 105 Tris Cl, 0.8
MgCl2.6H2O, 5.4 KCl, 20 BaCl2, 0.02
tetrodotoxin, and 10 HEPES. Ba2+ (20 mM) was
used as the charge carrier. All solutions were filtered (0.22 µm)
before use. The osmolarity was adjusted to 320 mosmol and the pH to
7.4. The membrane currents were measured using an Axon (Axopatch, ß =
1) whole cell patch clamp amplifier (Axon Instruments, Foster City,
CA). The data were sampled using pClamp software (pClamp 5.5) and a
Digidata 1200 analog-to-digital interface (Axon Instruments). Analysis
was performed using pClamp software. To generate current-voltage (I-V)
relationships, 250 msec depolarizing test pulses of increasing
amplitude were applied at a frequency of 0.3 Hz. On-line leakage
subtraction was implemented using the P/2 protocol in pClamp software.
At a holding potential of -50 mV hyperpolarizing pulses did not
activate any currents, and identical results were obtained with the P/2
or P/4 protocol. The experiments were performed at room temperature
(2022 C).
Pineal cells were evaluated for current run down before they were
used for experiments. After the whole cell configuration was
established, the current amplitude increased for 23 min due to
inhibition of the outward K+ current by intracellular
Cs+. When the current reached its peak amplitude, it was
monitored for an additional 5 min to estimate the run down rate. In
90% of cells, the initial run down rate was <5%, and a stable
current could be recorded for the next 30 min. In 10% of cells, the
initial run down rate was >5%. These cells tended to continue to run
down and were not used for experiments. If the initial run down rate
was less than 5%, the drugs were added into the bath solution after 5
min.
To determine steady state activation, the normalized conductance of
L-channels in the absence or presence of insulin or IGF-I was estimated
from the equation G = I/(VT - Vrev),
where G = normalized conductance, I = current, VT
= test potential, and Vrev = potential at the intersection
of the I-V relationship before and after 2 mM
La3+. The data points were least squares fitted to a
Boltzman function G = Gmax(1/1 +
exp(V1/2-Vx)k), where G = normalized
conductance, Gmax = maximal conductance, V1/2 =
voltage at which half of the channels are activated, Vx =
test voltage, and k = slope. Tail currents were measured by
depolarizing the cell from a holding potential of -60 to -10 mV with
repolarization to -40 mV. The depolarizing pulse length was set at 30
msec, and data were sampled at 10 KHz to obtain good resolution of the
fast (
1 msec) current tails. For the analysis of tail currents, the
first 350 µsec of the tail current was omitted to eliminate imperfect
capacitive transient cancellation.
Data are presented as the mean ± SEM
percentages of control values. At least three different cell
preparations were used for each study. The pretreatment I-V
relationship was plotted and used as a control. The effects of the
drugs were monitored continuously using depolarizing pulses at a
frequency of 0.03 Hz except when generating I-V relationships. The
paired t test was used for comparison between values of the
control and those obtained after drug administration. In the case of
multiple comparisons, ANOVA in conjunction with the Newman-Keuls test
was applied. Hill plots were used to determine median effective
concentration (EC50) values. Statistical significance was
set at P < 0.05.
cAMP and cGMP assays
cAMP and cGMP measurements were made on samples of cells (50,000
cells/500 µl) treated with various agents for 15 min; the RIA method
of measurement has been described in detail (24, 25).
 |
Results
|
|---|
Effects of insulin and IGF-I on L-type Ca2+ channel
current in rat pinealocytes
The only voltage-dependent Ca2+ channel current found
in dissociated pinealocytes is the dihydropyridine-sensitive
Ca2+ channel current (L-channel current) (18, 19, 26, 27).
When Ba2+ (20 mM) was used as the charge
carrier, and the current was activated by depolarizing the cell from a
holding potential of -50 to -10 mV, an inward current was measured
(Fig. 1A
). Bay K 8644 (1 µM), an L-channel
agonist, increased this current 3-fold, and nifedipine (10
µM), an L-channel antagonist, completely blocked this
current (Fig. 1
). Bay K 8644 shifted the peak of the L-channel current
towards more negative potentials (Fig. 1B
); this is consistent with the
dihydropyridine agonist causing an increase in channel mean open
time.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 1. L-channel current in rat pinealocytes. A,
L-channel current (20 mM Ba2+ charge carrier)
was activated by depolarizing cell from a holding potential of -50 to
-10 mV. Bay K 8644 (1 µM) increased current, and
nifedipine (10 µM) almost completely blocked this current
in presence of Bay K 8644. I-V relationships obtained from same cell
are shown on the right. B, Combined data from a group of
cells using same experimental protocol as described in A
are shown. Number of experiments are shown in
parentheses above histograms. *, P
< 0.05 compared with control current. Additional details are given in
Materials and Methods.
|
|
The effect of insulin on the L-channel current is shown in Fig. 2
. Insulin (1 µM) decreased the peak
amplitude of the L-channel current in a pinealocyte by about 42% (Fig. 2A
). It did not change the inactivation kinetics or shift the peak
inward current along its voltage axis, as shown in the I-V relationship
(Fig. 2B
). The inhibition of the L-channel current by insulin was
concentration-dependent (Fig. 2C
) with an EC50 value of 60
nM. No inhibition was seen with insulin (1 nM);
there was a 10% inhibition with 10 nM and a 54%
inhibition with 10 µM. Heat-inactivated insulin had no
significant effect on the L-channel current (Fig. 2C
, inset).
IGF-I also reduced the amplitude of the L-channel current (Fig. 3A
). IGF-I (10 nM) decreased the peak
current amplitude by about 45% in this experiment. The effect of IGF-I
was similar to that of insulin: there was a decrease in the current
amplitude but there was no change in the inactivation kinetics or shift
in the peak inward current along the voltage axis as shown in the I-V
relationship (Fig. 3B
). The effect of IGF-I on the L-channel current
was concentration dependent, with an EC50 value of 0.14
nM (Fig. 3C
). A 10% inhibition was seen with IGF-I (10
pM) and a 38% inhibition with 0.1 µM.
Heat-inactivated IGF-I had no significant effect on the L-channel
current (Fig. 3C
, inset).
The effects of insulin (1 µM) and IGF-I (10
nM) on the L-channel current as a function of time are
shown in Fig. 4
, B and C. The current run down from a
group of control cells is shown in Fig. 4A
for comparison. The onset of
the inhibition caused by insulin occurred within 24 min, and the
maximal inhibition was observed between 1216 min. The effect of
insulin was not reversed by washout (Fig. 4B
). The time course of the
IGF-I effect was similar to that of insulin. However, unlike the effect
of insulin, which was minimally reversed by washout, the effect of
IGF-I was 80% reversed by washout (Fig. 4C
).

View larger version (21K):
[in this window]
[in a new window]
|
Figure 4. Effect of insulin and IGF-I on L-channel current
in rat pinealocytes as a function of time. A, L-channel current run
down in rat pinealocytes. Run down was evaluated as described in
Materials and Methods. Peak L-channel current at 1-min
intervals were normalized to current 5 min after whole cell
configuration was established. Data from a group of cells (n = 6)
were plotted as mean ± SEM. B, Effect of insulin (1
µM) on L-channel current as a function of time. Insulin
was applied as indicated. Washout was started 17 min after insulin was
applied; effect of insulin was not reversed by washout. a, b and c are
peak currents at indicated times. (C) effect of IGF-I (10
nM) as a function of time. IGF-I was applied as indicated
and maximal effect was observed 15 min later. Washout was started 18
min after IGF-1 was applied; effect of IGF-I was reversed by washout.
a, b, and c are peak
inward currents at indicated times.
|
|
Additional parameters used to characterize the effects of insulin
and IGF-I on the L-channel current included steady state activation,
deactivation tail currents, and voltage dependence. The effect of
insulin and IGF-I on steady state activation is shown in Fig. 5
, A and B, respectively. Steady state activation was
calculated from the normalized conductance of L-channels. Insulin (1
µM) and IGF-I (10 nM) did not have a
significant effect on the voltage dependence of activation.
Deactivation tail currents, which give a more accurate measure of the
inward current, were used to establish that insulin and IGF-1 decreased
the peak and the tail current amplitude by the same percentage. Figure 5C
shows the effect of insulin (1 µM) on the tail current
amplitude. Insulin decreased the tail current amplitude in parallel
with the peak inward current. Similar results were obtained with IGF-I
(data not shown). Figure 5D
shows the inhibition of the L-channel
current by insulin (1 µM) as a function of membrane
potential. The maximal inhibition caused by insulin occurred at the
peak inward current. Therefore, changes in the peak inward current were
used to determine the effects of inhibitors and activators for all
subsequent studies.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 5. Effect of insulin and IGF-I on L-channel steady
state activation, tail current, and voltage dependence. A, Steady state
activation as described by normalized conductance in absence () or
presence ( ) of insulin (1 µM). Data points were
obtained as described in Materials and Methods.
Solid line is a least squares curve fit to Boltzman
function for data points in absence of insulin and dashed
line in presence of insulin. For solid
line, V1/2 = -13.0 mV, K = 7.4 and for
dashed line V1/2 = -14.0 mV, K = 7.2
(n = 6). B, Steady state activation as described by normalized
conductance in absence () or presence ( ) of IGF-I (10
nM). Data points were obtained and fitted as described in
A. For solid line, V1/2 =
-13.0 mV, K = 7.4 and for dashed line
V1/2 = -9.5 mV, K = 8.0 (n = 6). C, Effect of
insulin (1 µM) on tail currents. Two tail currents were
activated by depolarizing cell from a holding potential of -60 to -10
mV. A 350-µsec segment was blanked to remove imperfect transient
cancellation. Insulin decreased tail currents in parallel with peak
currents. D, Insulin-mediated L-channel inhibition plotted as a
function of membrane potential (n = 6).
|
|
The EC50 values of 60 nM for insulin and
0.14 nM for IGF-I suggest that these peptides may be
interacting with IGF-I receptors. This was assessed by using anti-IGF-I
receptor antibodies. Addition of anti-IGF-I receptor antibodies (1
µg/ml) had no effect on the L-channel current. However, in cells
pretreated with anti-IGF-I antibodies for 2 h, IGF-I (0.1
µM) no longer had an effect on the L-channel current
(Fig. 6
).
Comparisons with other growth factors
To determine the specificity of growth factors on the L-channel
current, the effects of NGF and EGF were investigated. Unlike insulin
and IGF-I, the effects of high concentrations of NGF (50 ng/ml)
(98.1 ± 4.9% of control, n = 5) and EGF (10 nM)
(93.2 ± 5.1% of control, n = 5) on the L-channel current
was not significant even after 20 min of drug treatment. After
treatment with EGF or NGF, the cells remained responsive to insulin (1
µM) (data not shown). Therefore, of the four growth
factors tested, only insulin and IGF-1 inhibited the L-channel
current.
Involvement of tyrosine phosphorylation
Because insulin and IGF-I are coupled to a family of receptor
tyrosine kinases (28), the involvement of tyrosine kinase in their
modulating effects on the L-channel current was investigated.
Lavendustin A (1 µM), a tyrosine kinase inhibitor (29),
was added to the bath solution before treatment with insulin as shown
in Fig. 7A
. Treatment with lavendustin A reduced the
L-channel current by 14 ± 6% (Fig. 7A
). In lavendustin A
pretreated cells, the inhibitory effect of insulin (1 µM)
was almost completely abolished (8 ± 5% vs. 52.8
± 3.9% in the presence and absence of lavendustin A) (Fig. 7B
). The
inactive compound, lavendustin B (0.1 mM), did not block
the effect of insulin on the L-channel current (data not shown). Figure 7C
shows the effect of lavendustin A and insulin on the L-channel
current in a single cell as a function of time. Similar results were
obtained with IGF-I (data not shown). These results suggest that
tyrosine phosphorylation is involved in the inhibitory effects of
insulin and IGF-I on the L-channel current.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 7. Effect of lavendustin A on insulin-mediated
inhibition of L-channel currents in rat pinealocytes. A, Lavendustin A
(1 µM) caused a small decrease in L-channel current. B,
In cells pretreated with lavendustin A, inhibitory effect of insulin (1
µM) was not significant. Number of experiments are shown
in parentheses above histograms. C, Effect of
lavendustin A on time course of inhibitory effect of insulin.
Pretreatment with lavendustin A (1 µM) significantly
blocked inhibitory effect of insulin on L-channel current.
|
|
Involvement of intracellular mechanisms
Because insulin and IGF-I are known to activate PI3-K (5, 6), the
effect of wortmannin, a specific PI3-K inhibitor (30), on the insulin
and IGF-I inhibition of the L-channel current was determined.
Wortmannin (1 µM), which had no effect on the basal
L-channel current, also had no effect on the inhibition by insulin or
IGF-I (data not shown).
Because insulin and IGF-I can activate PKC through phospholipase C-
(31), PKC may mediate the effect of these growth factors on the
L-channel current. This possibility was examined using a specific
inhibitor of PKC, calphostin C (32). Calphostin C (0.1
µM) had a small inhibitory effect on the L-channel
current (13.7 ± 3.6%) (Fig. 8
). In calphostin
C-pretreated cells, insulin (1 µM) caused an additional
25% reduction in the L-channel current (Fig. 8
, A and C). Although
calphostin C (0.1 µM) was only partially effective in
blocking the inhibition by insulin, it completely blocked the
inhibition by PMA (0.1 µM) (Fig. 8
, B and C). PMA (0.1
µM) alone reduced the amplitude of the L-channel current
by 37 ± 8% (Fig. 9
, A and B). In PMA-treated
cells, insulin (1 µM) caused an additional inhibition of
the L-channel current (Fig. 9
, A and B). Similar results were obtained
with IGF-I (data not shown). These results are consistent with the
involvement of PKC in the inhibitory effect of insulin and IGF-I on the
L-channel current.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 8. Effect of calphostin C on insulin- and
PMA-mediated inhibition of L-channel currents in rat pinealocytes. A,
L-channel current was activated by depolarizing cell from -50 to -0
mV. Calphostin C (CAL C, 0.1 µM) caused a small reduction
in L-channel current, and insulin (1 µM) caused a further
decrease in this current in presence of calphostin C. I-V relationships
obtained from same cell are shown on right. B, L-channel
current was activated by depolarizing cell from -50 to -10 mV.
Calphostin C (0.1 µM) was effective in blocking decrease
in L-channel current caused by PMA (0.1 µM). C, Combined
data from a group of cells using same experimental protocol as
described in A and B. Shown for
comparison are effect of insulin (1 µM) and PMA (0.1
µM). Number of experiments are shown in
parentheses above histograms. *, P
< 0.05 between different treatments.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Figure 9. Effect of PMA on insulin-mediated inhibition of
L-channel currents in rat pinealocytes. A, L-channel current was
activated by depolarizing cell from -50 to -0 mV. PMA (0.1
µM) decreased current, and insulin (1 µM)
caused a further decrease in this current in presence of PMA. I-V
relationships obtained from same cell are shown on
right. B, Combined data from a group of cells using same
experimental protocol as described in A are shown.
Number of experiments are shown in parentheses above
histograms. *, P < 0.05 between different
treatments.
|
|
Cyclic nucleotides are known to modulate the L-channel current in rat
pinealocytes (18, 19), and some effects of insulin and IGF-I are
mediated by cyclic nucleotides through their actions on
phosphodiesterases (33). Therefore the effect of insulin and IGF-I on
cAMP and cGMP accumulation was determined. Neither insulin nor IGF-I
had an effect on basal cAMP and cGMP accumulation (Table 1
).
 |
Discussion
|
|---|
There are several observations that suggest both IGF-I and insulin
may be important regulators of pineal function. First, messenger RNA
for IGF-I has been identified in the pineal gland during development
(15) suggesting that IGF-I, in addition to melatonin, may be a product
of the pineal gland. Second, IGF-I receptors have been found in the
pineal glands (16). Third, a mutation of the insulin receptor in man
results in pineal hyperplasia (34). In the present study, we examined
the regulatory role of insulin and IGF-I on L-channels in rat
pinealocytes. It was found that both insulin and IGF-I had an
inhibitory effect on the L-channel current. Because the
EC50 value for IGF-I is less than that for insulin in
inhibiting the L-channel current and the IGF-I-mediated inhibition is
not observed in cells treated with the anti-IGF-I receptor antibody,
these peptides are probably interacting with IGF-I receptors that are
present in the pineal gland (16). However, unlike the effect of IGF-I,
the effect of insulin could not be reversed by washout. Therefore, the
presence of insulin receptors in the rat pineal gland could not be
excluded. The effects of insulin and IGF-I are specific because not all
growth factors had an inhibitory effect on the L-channel current. NGF
and EGF had no effect on the L-channel current.
The established mechanism of action of insulin and IGF-I is through
tyrosine phosphorylation (28). The effect of insulin and IGF-I on the
L-channel current observed in this study also appears to be mediated
through tyrosine phosphorylation. This conclusion is based on the
observation that the inhibitory effects of insulin and IGF-I were
abolished in cells pretreated with lavendustin A, a tyrosine kinase
inhibitor, whereas the inactive inhibitor, lavendustin B, was
ineffective. Our results are in agreement with the known modulating
effects of insulin and IGF-I on the L-channel current in
GH4C1 (a pituitary tumor cell line) and 108CC15
(a N x G cell line) cells, and in Aplysia neurons (7, 10, 35). The effect of IGF-I on the L-channel current in
GH4C1 cells (10) and that of insulin in
Aplysia neurons (35) are also blocked by tyrosine kinase
inhibitors, indicating the involvement of tyrosine kinase.
In spite of this similarity, there are also distinct and significant
differences in the effects of insulin and IGF-I on the L-channel
current observed in the present study and in those mentioned above (7, 10, 35). First, unlike the rapid (24 min) effect of insulin and IGF-I
on the L-channel current in rat pinealocytes, the effects of these
growth factors in the N x G cells and in Aplysia
neurons are much slower (7, 35). In N x G cells, the effect of
IGF-I can only be observed after 1 h, and in Aplysia
neurons the effect of insulin is observed after 2040 min. Second,
whereas insulin and IGF-I increase Ca2+ channel activities
in the other studies (7, 10, 35), the effect of these two growth
factors in rat pinealocytes is inhibitory. Although the reason for
these differences in the modulation of the L-channel current by insulin
and IGF-I is unclear, the present study clearly demonstrates a rapid,
inhibitory effect of insulin and IGF-I on the L-channel current in rat
pinealocytes.
In a separate study, PKC has been shown to mediate the effect of IGF-I
on the L-channel current in the N x G cells (7). Our present
results support the involvement of PKC in the effect of insulin and
IGF-I on the L-channel current in rat pinealocytes. This is based on
the observation that pretreatment of the cells with a specific PKC
inhibitor, calphostin C, attenuated the inhibition of the L-channel
current by insulin and IGF-I. The inhibitory effect of insulin and
IGF-I was mimicked by PMA, a PKC activator, and the effects of PMA and
insulin were not additive.
In addition to PKC, other mechanisms activated by insulin and
IGF-I appear to modulate the L-channel because the PKC inhibitor,
calphostin C, was only partially effective in blocking the inhibition
by insulin and IGF-I, although it was completely effective in blocking
the inhibition by PMA. One mechanism activated by these growth factors
is PI3-K (5, 6). However, a specific PI3-K inhibitor, wortmannin, did
not block the effect of insulin and IGF-I on the L-channel current;
this argues against the involvement of PI3-K. A second mechanism
examined was phophodiesterase. Insulin and IGF-I, through their action
on phosphodiesterases (33), can elevate cAMP and cGMP, two known
modulators of L-channels (18, 19, 36). However, neither cAMP nor cGMP
is likely to be involved in the effect of insulin and IGF-I on the
L-channel current because these two growth factors have no effect on
cAMP or cGMP accumulation in rat pinealocytes. Therefore, neither PI3-K
nor cyclic nucleotides are involved in the effects of insulin and IGF-I
on the L-channel current.
It is of interest to note that both calphostin C and lavendustin
A have a small inhibitory effect on the L-channel current in rat
pinealocytes. Together with our previous observation that H7, a
nonspecific kinase inhibitor, has a small inhibitory effect on this
current (18), this result suggests that the basal channel activity is
under tonic regulation by protein phosphorylation. In agreement with
our results, other studies have shown that the basal activities of
several ion channels are regulated by protein phosphorylation (8, 9, 37, 38).
In summary, we found that physiological concentrations of insulin and
IGF-I have a rapid inhibitory action on the L-channel current. Tyrosine
phosphorylation is involved in these effects of insulin and IGF-I.
Furthermore, activation of PKC appears to be one of the mechanisms that
mediates these effects of insulin and IGF-I. These results add to the
existing evidence that insulin and IGF-I are potential regulators of
pineal function.
 |
Footnotes
|
|---|
1 This work was supported by a grant from the Medical Research Council
of Canada. 
2 C.L.C. and B.L. should be regarded as equal first authors. 
Received October 11, 1996.
 |
References
|
|---|
-
Fallon JH, Seroogy KB, Loughlin SE, Morrison RS,
Bradshaw RA, Knaver DJ, Cuningham DD 1984 Epidermal growth factor
immunoreactive material in the central nervous system: location and
development. Science 224:11071109[Abstract/Free Full Text]
-
Kar S, Chabot J-G, Quirion R 1993 Quantitative
autoradiographic localization of [125]insulin-like growth
factor I, [125]insulin-like growth factor II, and
[125]insulin receptor binding sites in developing and
adult rat brain. J Comp Neurol 333:375397[CrossRef][Medline]
-
Quirion R, Araujo D, Nair NP, Chabot JG 1988 Visualization of growth factor receptor sites in rat forebrain. Synapse 2:212218[CrossRef][Medline]
-
Puro DG, Agardh E 1984 Insulin-mediated regulation
of neuronal maturation. Science 225:11701172[Abstract/Free Full Text]
-
Kapeller R, Chen KS, Yoakim M, Schaffhausen BS, Backer
J, White MF, Cantley LC, Ruderman NB 1991 Mutations in the
juxtamembrane region of the insulin receptor impair activation of
phosphatidylinositol 3-kinase by insulin. Mol Endocrinol 5:769777[CrossRef][Medline]
-
Ruderman NB, Kapeller R, White MF, Cantley LC 1990 Activation of phosphatidyl-inositol 3-kinase by insulin. Proc Natl Acad
Sci USA 87:14111415[Abstract/Free Full Text]
-
Kleppisch T, Klinz F-J, Hescheler J 1992 Insulin-like growth factor I modulates voltage-dependent
Ca2+ channels in neuronal cells. Brain Res 591:283288[CrossRef][Medline]
-
Minami K, Fukuzawa K, Inoue I 1994 Regulation of a
non-selective cation channel of cultured porcine coronary artery smooth
muscle cells by tyrosine kinase. Pflugers Arch 426:254257[CrossRef][Medline]
-
Peppelenbosch MP, Tertoolen LG, den Hertog K, de Laat
SW 1992 Epidermal growth factor activates calcium channels by
phospholipase A2/5-lipoxygenase-mediated leukotriene
C4 production. Cell 69:295303[CrossRef][Medline]
-
Selinfreund RH, Blair LA 1994 Insulin-like growth
factor-1 induces a rapid increase in calcium currents and spontaneous
membrane activity in clonal pituitary cells. Mol Pharmacol 45:12151220[Abstract]
-
Wijetunge S, Hughes AD 1995 Effect of
platelet-derived growth factor on voltage-operated calcium channels in
rabbit isolated ear artery cells. Br J Pharmacol 115:534538[Medline]
-
Siegelbaum SA 1994 Channel regulation. Ion channel
control by tyrosine phosphorylation. Current Biol 4:242245[CrossRef][Medline]
-
Ho AK, Wiest R, Ogiwara T, Murdoch G, Chik CL 1995 Potentiation of adrenergic-stimulated cyclic AMP accumulation by
tyrosine kinase inhibitors in rat pinealocytes. J Neurochem 65:15971603[Medline]
-
Ogiwara T, Murdoch G, Chik CL, Ho AK 1995 Tyrosine
kinase inhibitors enhance cGMP production in rat pinealocytes. Biochem
Biophys Res Commun 207:9941002[CrossRef][Medline]
-
Ayer-Le Lievre C, Stahlbom P-A, Sara VR 1991 Expression of IGF-I and -II mRNA in the brain and craniofacial region
of the rat fetus. Development 111:105115[Abstract]
-
De Keyser J, Wilczak N, De Backer J-P, Herroelen L,
Vauguelin G 1994 Insulin-like growth factor-I receptors in human
brain and pituitary gland: an autoradiography study. Synapse 17:196202[CrossRef][Medline]
-
Smith M, Clemens J, Kerchner GA, Mendelsohn LG 1988 The insulin-like growth factor-II (IGF-II) receptor of rat brain:
regional distribution visualized by autoradiography. Brain Res 445:241246[CrossRef][Medline]
-
Chik CL, Liu Q-Y, Li B, Karpinski E, Ho AK 1995 cGMP inhibits L-type Ca2+ channel currents through protein
phosphorylation in rat pinealocytes. J Neurosci 15:31043109[Abstract]
-
Chik CL, Liu Q-Y, Li B, Klein DC, Zylka M, Kim DS, Chin
H, Karpinski Ho AK 1997
1D L-type Ca2+
channel currents: inhibition by a ß-adrenergic agonist and PACAP in
rat pinealocytes. J Neurochem 68:10781087[Medline]
-
Harrison NL, Zatz M 1989 Voltage-dependent calcium
channels regulate melatonin output from cultured chick pineal cells.
J Neurosci 9:24622467[Abstract]
-
Zatz M, Mullen DA 1988 Does calcium influx regulate
melatonin production through the circadian pacemaker in chick pineal
cells? Effects of nitrendipine, Bay K 8644, Co2+,
Mn2+, and low external Ca2+. Brain Res 463:305316[CrossRef][Medline]
-
Buda M, Klein DC 1978 A suspension culture of
pinealocytes: regulation of N-acetyltransferase activity. Endocrinology 103:14831493[Abstract]
-
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ 1981 Improved patch-clamp technique for high resolution current
recording from cells and cell-free membrane patches. Pflugers Arch 391:85100[CrossRef][Medline]
-
Harper JF, Brooker G Femtomole sensitive
radioimmunoassay for cyclic AMP and cyclic GMP after 2'-0 acetylation
by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res 1:207218
-
Ho AK, Chik CL, Klein DC 1987 Protein kinase C
is involved in adrenergic regulation of pineal cGMP accumulation.
J Biol Chem 262:1005910064[Abstract/Free Full Text]
-
Aguayo LG, Weight FF 1988 Characterization of
membrane currents in dissociated adult rat pineal cells. J Physiol
(London) 405:397491[Abstract/Free Full Text]
-
Chik CL, Liu Q-Y, Girard M, Karpinski E, Ho AK 1992 Inhibitory action of ethanol on L-type Ca2+ channels and
Ca2+-dependent guanosine 3',5'-monophosphate accumulation
in rat pinealocytes. Endocrinology 131:18951902[Abstract]
-
Petruzzelli LM, Ganguly S, Smith CJ, Cobb MH, Rubin CS,
Rosen OM 1982 Insulin activates a tyrosine-specific protein kinase
in extracts of 3T3L1 adipocytes and human placenta. Proc Natl Acad
Sci USA 79:67926796[Abstract/Free Full Text]
-
Hsu C-YJ, Persons PE, Spada AP, Bednar RA, Levitzki
A 1991 Kinetic analysis of the inhibition of the epidermal growth
factor receptor tyrosine kinase by lavendustin A and its analogue.
J Biol Chem 266:2110521112[Abstract/Free Full Text]
-
Bonser RW, Thompson NT, Randall RW, Tateson JE, Spacey
GD, Hodson HF, Garland LG 1991 Demethoxyviridin and wortmannin
block phospholipase C and D activation in the human neutrophil. Br
J Pharmacol 103:12371241[Medline]
-
Heidenreich KA, Toledo SP, Brunton LL, Watson MJ,
Danile-Issakani S, Strulovici B 1990 Insulin stimulates the
activity of a novel protein kinase C, PKC-epsilon, in cultured fetal
chick neurons. J Biol Chem 265:1507615082[Abstract/Free Full Text]
-
Kobayashi E, Nakano H, Morimoto H, Tamaoki T 1989 Calphostin C (UCN-1028C), a novel microbial compound, is a highly
potent and specific inhibitor of protein kinase C. Biochem Biophys Res
Commun 159:548553[CrossRef][Medline]
-
Sadler SE 1991 Type III phosphodiesterase plays a
necessary role in the growth-promoting actions of insulin, insulin-like
growth factor-I, and Ha p21ras in Xenopus laevis
oocytes. Mol Endocrinol 5:19391946[CrossRef][Medline]
-
Kadowaki T, Kadowaki H, Rechler MM, Serrano-Rios M, Roth
J, Gorden P, Taylor SI 1990 Five mutant alleles of the insulin
receptor gene in patients with genetic forms of insulin resistance.
J Clin Invest 86:254264
-
Jones AJ, Knoz RJ, Kaczmarek LK, Schwartz JH, Solomon
DH 1996 Insulin receptor in Aplysia neurons:
characterization, molecular cloning, and modulation of ion currents.
J Neurosci 16:16451658[Abstract/Free Full Text]
-
Hosey MM, Borsotto M, Lazdunski M 1986 Phosphorylation and dephosphorylation of the voltage dependent
Ca2+ channel in skeletal muscle membranes by cyclic AMP and
Ca2+-dependent processes. Proc Natl Acad Sci USA 83:37333737[Abstract/Free Full Text]
-
Saad AH, Kuo SS, Koong AC, Hahn GM, Giaccia AJ 1994
Modulation of potassium channels by protein tyrosine kinase inhibitors.
J Cell Physiol 161:142148
-
Wijetunge S, Aalkjaer C, Schachter M, Hughes AD 1992 Tyrosine kinase inhibitors block calcium channel currents in
vascular smooth muscle cells. Biochem Biophys Res Commun 189:16201623[CrossRef][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
J. Vela, M. I. Perez-Millan, D. Becu-Villalobos, and G. Diaz-Torga
Different kinases regulate activation of voltage-dependent calcium channels by depolarization in GH3 cells
Am J Physiol Cell Physiol,
September 1, 2007;
293(3):
C951 - C959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ibarra, M. Estrada, L. Carrasco, M. Chiong, J. L. Liberona, C. Cardenas, G. Diaz-Araya, E. Jaimovich, and S. Lavandero
Insulin-like Growth Factor-1 Induces an Inositol 1,4,5-Trisphosphate-dependent Increase in Nuclear and Cytosolic Calcium in Cultured Rat Cardiac Myocytes
J. Biol. Chem.,
February 27, 2004;
279(9):
7554 - 7565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Davis, X. Wu, T. R. Nurkiewicz, J. Kawasaki, P. Gui, M. A. Hill, and E. Wilson
Regulation of ion channels by protein tyrosine phosphorylation
Am J Physiol Heart Circ Physiol,
November 1, 2001;
281(5):
H1835 - H1862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sims, J. Chiu, and R. D. Harvey
Tyrosine Phosphatase Inhibitors Selectively Antagonize beta -Adrenergic Receptor-Dependent Regulation of Cardiac Ion Channels
Mol. Pharmacol.,
April 13, 2001;
58(6):
1213 - 1221.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. L. Chik, B. Li, T. Negishi, E. Karpinski, and A. K. Ho
Ceramide Inhibits L-Type Calcium Channel Currents in Rat Pinealocytes
Endocrinology,
December 1, 1999;
140(12):
5682 - 5690.
[Abstract]
[Full Text]
|
 |
|